Skip to main content
KMPHARMACEUTICAL Co.,Ltd. logo

KMPHARMACEUTICAL Co.,Ltd. — Investor Relations & Filings

Ticker · 225430 ISIN · KR7225430008 KO Manufacturing
Open in API
Filings indexed 234 across all filing types
Latest filing 2026-05-29 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 225430

About KMPHARMACEUTICAL Co.,Ltd.

https://en.kmkmp.com/

KMPHARMACEUTICAL Co., Ltd. is a company that develops, manufactures, and distributes personal care products. Its core business areas include oral care solutions, such as toothpaste and toothbrushes; beauty and skincare products; and a dedicated line of items for infants and children. The company leverages its research and development expertise to provide Original Equipment Manufacturer (OEM) and Original Design Manufacturer (ODM) services, creating customized products tailored to client needs in the oral care and cosmetics sectors. It focuses on developing innovative solutions and adheres to strict quality standards, particularly for its children's product lines.

Recent filings

Filing Released Lang Actions
[기재정정]분기보고서 (2026.03)
Interim / Quarterly Report Classification · 85% confidence The document is titled “정정신고” (amendment report) for a 분기보고서 (quarterly report), and contains full financial statements and detailed notes for the quarter, including corrected tables. It is not merely an announcement of a report or an officer’s certification. Under the taxonomy, a comprehensive interim/quarterly filing with substantive financial data is classified as an Interim / Quarterly Report (IR). Q1 2026
2026-05-29 Korean
주권매매거래정지해제 (액면병합 주권 변경상장)
Regulatory Filings Classification · 79% confidence The document is a regulatory announcement from the KOSDAQ exchange notifying the lifting of a trading suspension (“주권매매거래정지해제”), including itemized fields (security, reason, date, rule basis). It does not contain financial statements or decisions by management, nor is it an earnings release or report; it is a miscellaneous compliance/regulatory notice. Therefore it falls under Regulatory Filings (RNS).
2026-05-18 Korean
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 90% confidence The document is clearly titled “분기보고서” covering the period January 1 to March 31, 2026, and contains full company overviews, detailed tables on subsidiaries, capital changes, share information and other substantive financial data. This aligns exactly with the definition of an Interim/Quarterly Report. Therefore, it should be classified as IR. Q1 2026
2026-05-15 Korean
[기재정정]주식병합결정
Share Issue/Capital Change Classification · 100% confidence The document is a notice regarding a stock consolidation (주식병합결정) with detailed information about the stock consolidation schedule, share counts before and after consolidation, and related dates. It includes corrections to previously announced schedules and clarifies that the consolidation is not a capital reduction. The document is short (1587 characters) and primarily serves as an announcement of a corporate action related to capital structure changes (stock consolidation). There are no financial statements or detailed financial performance data. This fits the category of Share Issue/Capital Change (SHA), which covers announcements about new share issues, stock splits, or other capital changes such as stock consolidations.
2026-05-08 Korean
[기재정정]주식병합결정
Share Issue/Capital Change Classification · 100% confidence The document is a formal announcement regarding a stock consolidation (주식병합결정) decision by the company, including details such as the number of shares before and after consolidation, schedule dates, and board resolutions. It does not contain financial statements or detailed financial analysis but rather informs about a capital structure change. This fits the category of Share Issue/Capital Change (SHA) as it relates to changes in the company's share capital structure through stock consolidation.
2026-05-07 Korean
주주총회소집결의 (임시주주총회)
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a notice of convening a shareholders' meeting (임시주주총회 - extraordinary general meeting) with details on the meeting date, location, agenda items including amendments to the articles of incorporation and approval of executive compensation regulations. It is not a report or presentation but an official announcement to shareholders about the meeting. The document length is short (1094 characters) and it primarily serves as a meeting notice. Therefore, it fits the category of Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings.
2026-05-06 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.